Emergent BioSolutions Inc (EBS)
6.17
+0.13
(+2.15%)
USD |
NYSE |
Jun 14, 16:00
6.175
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Revenue (Annual): 1.023B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.023B |
| December 31, 2022 | 1.076B |
| December 31, 2021 | 1.639B |
| December 31, 2020 | 1.462B |
| December 31, 2019 | 983.50M |
| December 31, 2018 | 705.40M |
| December 31, 2017 | 490.40M |
| December 31, 2016 | 345.40M |
| December 31, 2015 | 371.94M |
| December 31, 2014 | 312.79M |
| December 31, 2013 | 257.92M |
| December 31, 2012 | 215.88M |
| Date | Value |
|---|---|
| December 31, 2011 | 202.41M |
| December 31, 2010 | 251.38M |
| December 31, 2009 | 234.79M |
| December 31, 2008 | 178.55M |
| December 31, 2007 | 182.92M |
| December 31, 2006 | 152.73M |
| December 31, 2005 | 130.69M |
| December 31, 2004 | 83.49M |
| December 31, 2003 | 55.77M |
| December 31, 2002 | 78.54M |
| December 31, 2001 | 45.31M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
983.50M
Minimum
2019
1.639B
Maximum
2021
1.237B
Average
1.076B
Median
2022
Revenue (Annual) Benchmarks
| Macrogenics Inc | 57.19M |
| Verrica Pharmaceuticals Inc | 5.124M |
| Recursion Pharmaceuticals Inc | 43.88M |
| Omega Therapeutics Inc | 3.094M |
| Context Therapeutics Inc | -- |